Initial studies show a significant drop in infections and hospitalizations after just one dose, and very few cases after two. Experts caution that the results are preliminary.Initial studies show a significant drop in infections and hospitalizations after just one dose, and very few cases after two. Experts caution that the results are preliminary.Vaccination and Immunization, Politics and Government, Disease Rates, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Pfizer Inc, IsraelRead More
